Literature DB >> 11009455

PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes.

R C Li1, P Ping, J Zhang, W B Wead, X Cao, J Gao, Y Zheng, S Huang, J Han, R Bolli.   

Abstract

We have previously shown that protein kinase C (PKC)-epsilon, nuclear factor (NF)-kappaB, and mitogen-activated protein kinases (MAPKs) are essential signaling elements in ischemic preconditioning. In the present study, we examined whether activation of PKCepsilon affects the activation of NF-kappaB in cardiac myocytes and whether MAPKs are mediators of this signaling event. Activation of PKCepsilon (+108% above control) in adult rabbit cardiomyocytes to a degree that has been previously shown to protect myocytes against hypoxic injury increased the DNA-binding activity of NF-kappaB (+164%) and activator protein (AP)-1 (+127%) but not that of Elk-1. Activation of PKCeta did not have an effect on these transcription factors. Activation of PKCepsilon also enhanced the phosphorylation activities of the p44/p42 MAPKs and the p54/p46 c-Jun NH(2)-terminal kinases (JNKs). PKCepsilon-induced activation of NF-kappaB and AP-1 was completely abolished by inhibition of the p44/p42 MAPK pathway with PD98059 and by inhibition of the p54/p46 JNK pathway with a dominant negative mutant of MAPK kinase-4, indicating that both signaling pathways are necessary. Taken together, these data identify NF-kappaB and AP-1 as downstream targets of PKCepsilon, thereby establishing a molecular link between activation of PKCepsilon and activation of NF-kappaB and AP-1 in cardiomyocytes. The results further demonstrate that both the p44/p42 MAPK and the p54/p46 JNK signaling pathways are essential mediators of this event.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009455     DOI: 10.1152/ajpheart.2000.279.4.H1679

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  31 in total

1.  Tribulosin protects rat hearts from ischemia/reperfusion injury.

Authors:  Shuang Zhang; Hong Li; Shi-jie Yang
Journal:  Acta Pharmacol Sin       Date:  2010-05-10       Impact factor: 6.150

Review 2.  Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning.

Authors:  Michael Zaugg; Marcus C Schaub
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

3.  The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition.

Authors:  Marika Massaro; Aida Habib; Laura Lubrano; Serena Del Turco; Guido Lazzerini; Todd Bourcier; Babette B Weksler; Raffaele De Caterina
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-03       Impact factor: 11.205

4.  Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition.

Authors:  L X Zhang; Y Zhao; G Cheng; T L Guo; Y E Chin; P Y Liu; T C Zhao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

5.  Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction.

Authors:  Yiru Guo; Marcin Wysoczynski; Yibing Nong; Alex Tomlin; Xiaoping Zhu; Anna M Gumpert; Marjan Nasr; Senthikumar Muthusamy; Hong Li; Michael Book; Abdur Khan; Kyung U Hong; Qianhong Li; Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2017-02-16       Impact factor: 17.165

Review 6.  Aldosterone and inflammation.

Authors:  Kimberly C Gilbert; Nancy J Brown
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

7.  Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair.

Authors:  Parul Mehra; Yiru Guo; Yibing Nong; Pawel Lorkiewicz; Marjan Nasr; Qianhong Li; Senthilkumar Muthusamy; James A Bradley; Aruni Bhatnagar; Marcin Wysoczynski; Roberto Bolli; Bradford G Hill
Journal:  Basic Res Cardiol       Date:  2018-10-23       Impact factor: 17.165

8.  Sulindac confers high level ischemic protection to the heart through late preconditioning mechanisms.

Authors:  Ian Moench; Howard Prentice; Zach Rickaway; Herbert Weissbach
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

Review 9.  Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.

Authors:  Nancy J Brown
Journal:  Nat Rev Nephrol       Date:  2013-06-18       Impact factor: 28.314

10.  Sequential activation of protein kinase C isoforms by organic dust is mediated by tumor necrosis factor.

Authors:  Todd A Wyatt; Rebecca E Slager; Arthur J Heires; Jane M Devasure; Susanna G Vonessen; Jill A Poole; Debra J Romberger
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-27       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.